Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > ------DOUBLE DIGITS---

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Jun 09, 2020 11:16am

29 Views

Post# 31128763

RE:------DOUBLE DIGITS---

You make absolutely no sense whatso ever !!!! Do you work for the Brokers ???

threefiftynine wrote:
NO ONE in their right mind will buy in to a pp that trades at orlower than the offering ---MPARTNERS couldn't promote a lolly stand ---but lets go with "SILENCE IS GOLDEN" for a while longer and see how that works out.

<< Previous

Bullboard Posts

Next >>

Fortuna reports record earnings for Q3 2024